TY  - JOUR
T1  - DMaa as a dietary supplement ingredient
AU  - Cohen PA
Y1  - 2012/07/09
N1  - 10.1001/archinternmed.2012.1677
JO  - Archives of Internal Medicine
SP  - 1038
EP  - 1039
VL  - 172
IS  - 13
N2  - 
The pharmaceutical amphetamine derivative 1,3-dimethylamylamine (DMAA) was introduced in 1948 as a nasal inhaler for rhinitis by Eli Lilly & Co. By the 1970s, it had been withdrawn as an approved pharmaceutical. Surprisingly, DMAA is currently used as an ingredient in roughly 200 sports supplements, many sold in major franchises throughout the United States, with sales topping $100 million in 2010 alone (Table).1- 4

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2012.1677
UR  - http://dx.doi.org/10.1001/archinternmed.2012.1677
ER  -